Talaris Therapeutics

-$0.47 (-2.72%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TALS and other stocks, options, and ETFs commission-free!

About TALS

Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT).

CEO
Scott Requadt
Employees
90
Headquarters
Louisville, Kentucky
Founded
2002

TALS Key Statistics

Market Cap
691.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
155.14K
High Today
$18.40
Low Today
$16.65
Open Price
$17.14
Volume
158.02K
52 Week High
$19.82
52 Week Low
$11.42

TALS Earnings

-$1.30
-$0.87
-$0.43
$0.00
Q1 FY21
Estimated
— per share
Actual
-$1.30 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure